Literature DB >> 18065411

Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.

Simone Cagnacci1, Laura Gualco, Simona Roveta, Stefania Mannelli, Luisa Borgianni, Jean-Denis Docquier, Ferdinando Dodi, Monica Centanaro, Eugenio Debbia, Anna Marchese, Gian Maria Rossolini.   

Abstract

OBJECTIVES: To investigate the first Italian outbreak of bloodstream infections caused by multidrug-resistant (MDR) Klebsiella pneumoniae producing metallo-beta-lactamase (MBL), which occurred in three wards of one large tertiary-care hospital in Genoa, Italy, from September 2004 to March 2005.
METHODS: MBL production was screened by an imipenem-EDTA disc synergy test and confirmed by a conventional hydrolysis test. Antibiotic susceptibility was determined by broth microdilution or disc diffusion. PFGE was used to study the genetic relatedness of isolates. PCR and sequencing were carried out to identify the beta-lactamase genes and to analyse the genetic context of the MBL gene. Outer membrane protein (OMP) profiles were analysed by SDS-PAGE.
RESULTS: Nine cases of bloodstream infections caused by an MDR strain of K. pneumoniae producing the VIM-1 MBL and the SHV-5 extended-spectrum beta-lactamase (ESBL) were identified. The isolates exhibited various carbapenem resistance levels (imipenem MICs ranged from 4 to 64 mg/L) and were resistant to other beta-lactams, fluoroquinolones, trimethoprim/sulfamethoxazole and chloramphenicol. The isolate with the highest imipenem MIC also lacked the k36 OMP. The bla(VIM-1) gene cassette was part of the variable region of a class 1 integron that also included an aac(6')-IIc cassette. The ESBL and MBL genes were transferable by conjugation.
CONCLUSIONS: This is the first report on the emergence of an MDR strain of K. pneumoniae producing the VIM-1 MBL, causing an outbreak of bloodstream infections in an Italian hospital. The strain evolved through OMP alterations generating a mutant with increased carbapenem resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065411     DOI: 10.1093/jac/dkm471

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.

Authors:  Costas C Papagiannitsis; Simona Pollini; Filomena De Luca; Gian Maria Rossolini; Jean-Denis Docquier; Jaroslav Hrabák
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

2.  Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

Authors:  Isabel Sánchez-Romero; Angel Asensio; Jesús Oteo; María Muñoz-Algarra; Beatriz Isidoro; Ana Vindel; José Alvarez-Avello; Bárbara Balandín-Moreno; Oscar Cuevas; Sara Fernández-Romero; Luisa Azañedo; David Sáez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2011-10-17       Impact factor: 5.191

3.  Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.

Authors:  Amélie Carrër; Laurent Poirel; Haluk Eraksoy; A Atahan Cagatay; Selim Badur; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

4.  Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.

Authors:  Frédéric Robin; Nadjet Aggoune-Khinache; Julien Delmas; Malek Naim; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

5.  First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.

Authors:  Gian Maria Rossolini; Francesco Luzzaro; Roberta Migliavacca; Claudia Mugnaioli; Beatrice Pini; Filomena De Luca; Mariagrazia Perilli; Simona Pollini; Melissa Spalla; Gianfranco Amicosante; Antonio Toniolo; Laura Pagani
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

Review 6.  Impact of borderline minimum inhibitory concentration on the outcome of invasive infections caused by Enterobacteriaceae treated with β-lactams: a systematic review and meta-analysis.

Authors:  E Torres; M Delgado; A Valiente; Á Pascual; J Rodríguez-Baño
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-02       Impact factor: 3.267

7.  Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain.

Authors:  E Miró; J Agüero; M N Larrosa; A Fernández; M C Conejo; G Bou; J J González-López; N Lara; L Martínez-Martínez; A Oliver; B Aracil; J Oteo; A Pascual; J Rodríguez-Baño; L Zamorano; F Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-07       Impact factor: 3.267

Review 8.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

9.  Dispersal of carbapenemase blaVIM-1 gene associated with different Tn402 variants, mercury transposons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Marta Tato; Teresa M Coque; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

10.  Emergence of KPC-producing Klebsiella pneumoniae in Italy.

Authors:  Carla Fontana; Marco Favaro; Loredana Sarmati; Silvia Natoli; Anna Altieri; Maria C Bossa; Silvia Minelli; Francesca Leonardis; Cartesio Favalli
Journal:  BMC Res Notes       Date:  2010-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.